Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)

v3.24.1.1.u2
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Income Statement [Abstract]    
Revenues $ 282 $ 2,101
Cost of goods sold 49 967
Gross loss 233 1,134
Operating expenses:    
General and administrative 198,847 347,297
Professional fees 578,671 103,848
Depreciation expense 7,857
Total operating expenses 777,518 459,002
Operating loss (777,285) (457,868)
Other income (expense):    
Loss on early extinguishment of debt (724,086)
Loss on deconsolidation of foreign subsidiaries (97,672)
Interest expense (101,979) (58,070)
Total other expense (923,737) (58,070)
Net loss (1,701,022) (515,938)
Other comprehensive loss:    
Gain (loss) on foreign currency translation (42,328) 184,969
Net other comprehensive loss (1,743,350) (330,969)
Series A convertible preferred stock declared ($0.60 per share) (14,916) (12,773)
Net loss attributable to common shareholders $ (1,758,266) $ (343,742)
Weighted average number of common shares outstanding - basic 86,930,048 68,702,907
Weighted average number of common shares outstanding - diluted 86,930,048 68,702,907
Net loss per share - basic $ (0.02) $ (0.01)
Net loss per share - diluted (0.02) (0.01)
Dividends declared per share of common stock $ 0.00 $ 0.00